Immunotherapy Drug Keytruda Approved For Colon Cancer Patients With Specific Tumor Abnormalities

Updated April 13th, 2022

Immunotherapy Drug Keytruda Approved For Colon Cancer Patients With Specific Tumor Abnormalities

A new option for the treatment of metastatic colorectal cancer, immune checkpoint inhibitor Keytruda, has been approved by the FDA -- marking historic progress for certain patients

NOW
PLAYING
'JoJo's Bizarre Adventure' Star Billy Kametz, 35, Announces Stage 4 Colon Cancer, Will 'Take Time Off' Show
NOW
PLAYING
Changing the Way CLL is Treated: What are BTK Inhibitors?
NOW
PLAYING
How Does Atezolizumab (Tecentriq) Treat Lung Cancer?
NOW
PLAYING
How is Rectal Cancer Treated Differently Than Colon Cancer?
NOW
PLAYING
Biomarkers in Colon Cancer: What Does High Microsatellite Instability Mean?
NOW
PLAYING
How is Melanoma Treated After Surgery?

Treatment: Making Wise Surgery Decisions

SEE MORE   

Treatment: Making Wise Surgery Decisions

There is plenty of marketing information out there about the best surgery techniques, and the best places to have your operation done. Doing your own research is crucial before committing to any treatment.

×

Introducing, the Journey Bar

Use this bar to access information about the steps in your cancer journey.